2022
DOI: 10.1080/15384101.2022.2122258
|View full text |Cite
|
Sign up to set email alerts
|

Expression of the cytokinesis regulator PRC1 results in p53-pathway activation in A549 cells but does not directly regulate gene expression in the nucleus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 45 publications
0
2
0
Order By: Relevance
“…In another study, the number of cancer cells blocked at the G2/M phase was higher after the knockdown of PRC1 in colon cancer, which reduced the invasive ability of colon cancer 47 . Previous studies on tumors report cytoplasmic division failure as a significant risk factor for tumor development and progression, and PRC1 overexpression may lead to impaired cytoplasmic division and chromosomal instability, which could be one of the oncogenic mechanisms of PRC1 48 . In addition, PRC1 overexpression reportedly activates the Wnt/β-catenin signaling pathway to promote the progression of hepatocellular carcinoma and lung adenocarcinoma 49 50 .…”
Section: Discussionmentioning
confidence: 99%
“…In another study, the number of cancer cells blocked at the G2/M phase was higher after the knockdown of PRC1 in colon cancer, which reduced the invasive ability of colon cancer 47 . Previous studies on tumors report cytoplasmic division failure as a significant risk factor for tumor development and progression, and PRC1 overexpression may lead to impaired cytoplasmic division and chromosomal instability, which could be one of the oncogenic mechanisms of PRC1 48 . In addition, PRC1 overexpression reportedly activates the Wnt/β-catenin signaling pathway to promote the progression of hepatocellular carcinoma and lung adenocarcinoma 49 50 .…”
Section: Discussionmentioning
confidence: 99%
“…Targeting PRC1 expression or function may result in therapeutic vulnerabilities in cancer treatment [40]. Bioinformatics analysis has revealed that PRC1 may be a prognostic biomarker for predicting OS in LUAD.…”
Section: Construction Of the Ppi Network And Identification Of Key Genesmentioning
confidence: 99%